- Efficacy of anti-VEGF therapy (aflibercept) in advanced colorectal cancer2019 | Publication without faculty affiliation
- Interactions Between Anti-Vegf Therapy and Antitumor Immunity as a Potential Therapeutic Strategy in Colorectal Cancer2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Physical Education and Sport
- Efficacy of anti-VEGF therapy with afliberceptem in advanced colorectal cancer2017 | Publication without faculty affiliation
- Brolucizumab - A New Player In The Field Of Anti-VEGF Therapy Of Neovascular Age-Related Macular Degeneration. A Review2022 | First Faculty of Medicine
- Cardiotoxicity of antitumor drugs in ovarian cancer patients2015 | Faculty of Medicine in Hradec Králové
- One-year follow-up outcomes of the treatment of wet age-related macular degeneration with aflibercept2018 | Third Faculty of Medicine
- Effect of baseline central retinal thickness on the results of treatment of diabetic macular edema with aflibercept: real-life evidence in the Czech republic2022 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trialPublication without faculty affiliation
- Two-year results of a combined regimen of aflibercept treatment in three types of choroidal neovascular membrane in the wet form of age-related macular degeneration: Real-life evidence in the Czech Republic2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Proteinuria and Hypertension in Patients Treated with Inhibitors of the VEGF Signalling Pathway - Incidence, Mechanisms and Management2013 | First Faculty of Medicine
- Ranibizumab (Lucentis) in the Treatmnet of Age-Related Macular Degeneration +12009 | Faculty of Medicine in Hradec Králové
- Ranibizumab (Lucentis) in the Treatmnet of Age-Related Macular Degeneration2009 | First Faculty of Medicine
- Correlation of Vitreous Vascular Endothelial Growth Factor and Uric Acid Concentration Using Optical Coherence Tomography in Diabetic Macular Edema2015 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Diabetic macular edema treatment with subthreshold micropulse laser - five-year long monitoring2023 | Faculty of Medicine in Hradec Králové
- Familial Limbal Stem Cell Deficiency: Clinical, Cytological and Genetic Characterization2018 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
